| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |